---
$id: https://graph.org.ai/products/commodity/51172132
$type: Product
source: UNSPSC
code: "51172132"
title: "Moxaverine or moxaverine hydrochloride"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moxaverine or moxaverine hydrochloride

**UNSPSC Code**: 51172132
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formulas C20H21NO2 and C20H21NO2.ClH, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers P3P08Y1XJ4, chemically known as 3-ethyl-1-benzyl-6,7-dimethoxyisoquinoline but generally known as moxaverine, which bears US NIH Compound Identifier 70882. European Medicines Agency schedules Moxaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB09082MIG and SUB03341MIG. The term MOXAVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules moxaverine in its Anatomical Therapeutic Chemical (ATC) Classification. MOXAVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moxaverine and its salts under HS 29334990 and SITC 51575. As of Q4 2014, MOXAVERINE remains the US FDA Preferred Term for this commodity. Moxaverine bears US NLM NCI C66209. SMILES: O(C1CC2C(NC(CC2CC1OC)CC)CC1CCCCC1)C (base) and CCC1CC2CC(C(CC2C(N1)CC3CCCCC3)OC)OC.CL (hydrochloride).

